Importation of US-Authorized Vasopressin Injection, USP, 20 units/mL (For IV Infusion) Due to the Current Shortage of Canadian-Authorized Vasopressin Injection, USP, 20 units/mL (For IM or SC Administration)

There is a shortage of Vasopressin Injection, USP, 20 units/mL (for intramuscular [IM] or subcutaneous [SC] administration) in Canada. This shortage presents serious risks to patients who may require vasopressin therapy in critical care settings, based on the clinical judgment of qualified healthcare professionals. Given the medical need, Health Canada has permitted the exceptional, temporary importation and sale of a similar but not identical product, US-authorized Vasopressin, USP, 20 units/mL (for intravenous [IV] infusion), with English-only labels by Fresenius Kabi USA, LLC.

Product safety - Packaging - Supply

See Key Messages below

US-Authorized Vasopressin Injection, USP, 20 units/mL (For IV Infusion)

RA-81664